# A Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function

> **NCT00421044** · PHASE1 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 14 (actual)

## Conditions studied

- Advanced Malignancies
- Tumors

## Interventions

- **DRUG:** Patupilone/EPO906

## Key facts

- **NCT ID:** NCT00421044
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2008-02
- **Final completion:** —
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2012-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00421044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00421044, "A Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00421044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*